Cionic's AI-Powered Bionic Clothing Reimagines Mobility for Millions

SAN FRANCISCO, CA – March 24, 2026 – Cionic, a pioneering neurotechnology company, has been named to Fast Company's prestigious annual list of the World's Most Innovative Companies for 2026. The recognition, which places Cionic as a leader in the Medical Device sector, spotlights its FDA-cleared Neural Sleeve, a form of AI-powered bionic clothing designed to restore mobility for individuals with over 20 neurological conditions, including multiple sclerosis, stroke, and spinal cord injury.

This accolade validates a new direction in medical technology, one where intelligent, adaptive systems are integrated directly into the fabric of daily life. "From our earliest days, we've known that reimagining mobility care isn't just about building better technology, but about changing the culture of innovation in med tech," said Cionic CEO and founder Jeremiah Robison. The award affirms the company's success in advancing innovation across its entire product ecosystem to fulfill its mission to "superpower movement."

A New Paradigm in Neuro-Mobility

At the heart of Cionic's innovation is the Neural Sleeve 2, the second generation of its core product released in September 2025. Unlike traditional medical devices, the Neural Sleeve is a soft, comfortable garment that houses a dense array of sensors and electrodes. These components work in concert with a sophisticated AI to read the body's own neural signals and deliver precise electrical pulses—a technique known as Functional Electrical Stimulation (FES)—to orchestrate muscle movement.

The Neural Sleeve 2 introduced a groundbreaking technology called MultiStim, an entirely new stimulation paradigm. While conventional FES devices typically target a single muscle group for a single purpose, such as lifting the foot to prevent foot drop, MultiStim choreographs a full gait cycle. It combines multiple, coordinated pulse trains to activate and relax the quads, hamstrings, shin, and calf muscles with every step.

Crucially, the Neural Sleeve 2 is the first FDA-cleared device of its kind to simultaneously activate muscle movement and relax muscle spasms. This dual-action capability addresses spasticity, a debilitating and often painful condition characterized by muscle tightness and stiffness that is a common barrier to movement for a high percentage of stroke survivors and individuals with MS. By tackling both muscle weakness and spasticity, Cionic provides a more holistic solution than what has been previously available.

From Lab to Life: The Real-World Impact

The true measure of Cionic's innovation is found in the lives it has changed. The company's community of thousands of users has collectively traversed more than 500 million steps and logged over 2 million hours of real-world wear. Clinical data backs up these numbers, with studies showing significant improvements in gait. In back-to-back tests, 94% of participants demonstrated improved walking, reporting an average 68% increase in foot clearance and a 44% improvement in ankle stability. A trial of 45 users also observed a highly significant 30% reduction in spasticity.

Beyond the data, the human stories are powerful. One physical therapist overseeing patients using the device noted a virtuous cycle of improvement. "They can do much more activity. They can get out and be active during the day," the therapist observed. "Because you're contracting the muscles, the muscles get stronger. You're able to walk more, so you're building up strength. It's almost like a feedback loop. I just see continued improvement in my patients who use it."

Users have reported regaining confidence and independence. One individual with MS described gaining "phenomenal" endurance after just 10 days, allowing them to walk on uneven cobblestones without fear. Another, a stroke survivor, found the device "fantastic" in their recovery, enabling them to move "much faster and safer" and regaining "the spark back in my life."

Redefining the Medical Device Industry

Cionic's recognition by Fast Company is not just for a single product, but for its entire approach, which is setting a new pace for the industry. The release of the Neural Sleeve 2 just two years after the first generation demonstrates a speed of innovation described as "unparalleled in the medical device industry," which is traditionally known for long development cycles.

This rapid iteration is made possible by a philosophy that blends technology with human-centered design. In partnership with the world-class design agency fuseproject, Cionic has transformed a powerful medical device into something people actually want to wear. The Neural Sleeve 2 is 25% lighter and has 30% less wiring than its predecessor, resembling sleek athletic gear rather than a cumbersome medical apparatus, thereby reducing stigma and encouraging consistent use.

This reflects a broader trend highlighted by Fast Company's awards. "The companies we honor this year are redefining what leadership looks like in 2026, pairing bold ideas with measurable impact," said Brendan Vaughan, editor-in-chief of Fast Company. Cionic exemplifies this by building a complete ecosystem—a wearable that pairs with an app for tracking progress and a service that connects every user with a dedicated Mobility Specialist for personalized care and adjustments.

Navigating a Complex and Competitive Landscape

Cionic operates in a market that includes rigid, clinic-based exoskeletons and simpler, single-purpose FES devices. The Neural Sleeve carves out a unique space as a comprehensive, AI-driven system designed for everyday life. Its subscription-based model—which includes the hardware, software, and personalized support—makes the technology more accessible than a large upfront purchase and is backed by a "Step Together Guarantee" that allows users to return the device if it doesn't meet their needs.

Looking ahead, Cionic is poised for continued growth, fueled by a robust research and development pipeline. The company is actively conducting new research into applications for Parkinson's disease and holds a growing portfolio of patents for its AI system that predicts a user's physical intent to facilitate natural movement. Sustained collaborations with 25 leading clinical, research, and advocacy partners, including Stanford University and the Shirley Ryan AbilityLab, ensure its technology remains at the forefront of mobility science.

By integrating advanced AI, wearable design, and a human-centric service model, Cionic is not just creating an innovative product. It is building a new operating system for human movement, offering a blueprint for how technology can be seamlessly woven into our lives to restore function, inspire hope, and truly superpower movement.